James Ballenger to Agoraphobia
This is a "connection" page, showing publications James Ballenger has written about Agoraphobia.
Connection Strength
0.854
-
Comment on the London/Toronto Study of Alprazolam and Exposure in Panic Disorder with Agoraphobia. Br J Psychiatry. 1993 Jun; 162:788-9; discussion 790-4.
Score: 0.104
-
Efficacy of benzodiazepines in panic disorder and agoraphobia. J Psychiatr Res. 1990; 24 Suppl 2:15-25.
Score: 0.082
-
Phenelzine treatment of panic disorder: lack of effect on pyridoxal phosphate levels. J Clin Psychopharmacol. 1989 Dec; 9(6):428-31.
Score: 0.082
-
Three cases of panic disorder with agoraphobia in children. Am J Psychiatry. 1989 Jul; 146(7):922-4.
Score: 0.079
-
Possible relationship of bowel obsessions to panic disorder with agoraphobia. Am J Psychiatry. 1988 Oct; 145(10):1324-5.
Score: 0.075
-
Unrecognized prevalence of panic disorder in primary care, internal medicine and cardiology. Am J Cardiol. 1987 Dec 28; 60(18):39J-47J.
Score: 0.071
-
Antidepressants in panic disorder and agoraphobia. J Affect Disord. 1987 Sep-Oct; 13(2):153-68.
Score: 0.070
-
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998 Jan; 155(1):36-42.
Score: 0.036
-
Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia. Am J Psychiatry. 1992 Nov; 149(11):1556-62.
Score: 0.025
-
The effects of pregnancy on preexisting panic disorder. J Clin Psychiatry. 1992 Jun; 53(6):201-3.
Score: 0.024
-
A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol. 1992 Apr; 12(2):96-103.
Score: 0.024
-
Sequence of improvement in agoraphobia with panic attacks. J Psychiatr Res. 1990; 24(1):1-8.
Score: 0.021
-
CSF prostaglandin-E in agoraphobia with panic attacks. Biol Psychiatry. 1989 Jul; 26(3):257-64.
Score: 0.020
-
Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. J Affect Disord. 1989 Jan-Feb; 16(1):49-58.
Score: 0.019
-
Different rates of improvement of different symptoms in combined pharmacological and behavioral treatment of agoraphobia. J Behav Ther Exp Psychiatry. 1988 Jun; 19(2):119-26.
Score: 0.018
-
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry. 1988 May; 45(5):423-8.
Score: 0.018
-
Alprazolam in the treatment of social phobia. J Clin Psychiatry. 1988 Jan; 49(1):17-9.
Score: 0.018
-
Pharmacotherapy of the panic disorders. J Clin Psychiatry. 1986 Jun; 47 Suppl:27-32.
Score: 0.016
-
The dexamethasone suppression test in agoraphobia. J Clin Psychopharmacol. 1985 Apr; 5(2):100-2.
Score: 0.015
-
Psychopharmacology of the anxiety disorders. Psychiatr Clin North Am. 1984 Dec; 7(4):757-71.
Score: 0.014
-
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
Score: 0.010
-
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
Score: 0.007
-
CSF diazepam-binding inhibitor concentrations in panic disorder. Biol Psychiatry. 1992 Oct 15; 32(8):712-6.
Score: 0.006